From April 1, 2024 to April 9, 2024, the company has repurchased 600,000 shares, representing 0.11% for CNY 10.48 million. With this, the company has completed the repurchase of 1,260,000 shares, representing 0.23% for CNY 29.87 million under the buyback announced on October 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.89 CNY | +2.36% | -3.00% | -44.77% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.77% | 1.02B | |
+48.53% | 779B | |
+40.67% | 631B | |
-6.37% | 354B | |
+20.93% | 333B | |
+8.21% | 301B | |
+16.75% | 249B | |
-1.19% | 216B | |
+10.85% | 214B | |
+4.40% | 163B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.